Driver of cystic fibrosis lung inflammation yields target for treatment
Yale researchers have uncovered a driver of the chronic inflammation that damages lungs in cystic fibrosis. It could be a target for treatment.
Stay updated with breaking news from Jonas Schupp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Yale researchers have uncovered a driver of the chronic inflammation that damages lungs in cystic fibrosis. It could be a target for treatment.
By Bill Hathaway May 25, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (Illustration by Michael S. Helfenbein) The primary function of the lung is to facilitate transfer of oxygen to the blood stream. Crucial to this lifegiving task are endothelial cells, which line blood vessels permeating the lung and through which gas exchange occurs. Malfunction of these cells is implicated in a range of different diseases, including COPD (chronic obstructive pulmonary disease), pulmonary fibrosis, and pulmonary hypertension. And the COVID-19 p...
A reference map of endothelial cells in the lungs was created to help researchers identify specific abnormalities that occur in a host of lung diseases